Drug Screening

The FCG works with investigators to perform all necessary assay optimization and validation. The FCG staff then translates the protocol into a high throughput workflow on our liquid handling workstation and works with the researchers to perform their compound screen. The primary limit on the throughput of the screen is the speed of the assay. Simple fluorescence based assays can be read on our BioTek Synergy 2 or our Attune flow cytometer, while complex cell phenotyping can be performed on our Operetta CLS.


Do you have a novel Drug Target? (link is external)

Warren Hoe (link sends e-mail)
Business Development Associate
BIO5 Institute
The University of Arizona

Related  Services: